Trastuzumab Completed Phase 1 Trials for Recurrent Endometrial Carcinoma / Recurrent Ovarian Epithelial Cancer / Male Breast Cancer / Non-Small Cell Lung Cancer Recurrent / refractory Small cell lung cancer / Recurrent Gastric Cancer / Recurrent Breast Cancer Treatment